Cassava Laying off One-third of Staff to Curb Expenses

Seeking AlphaJan 8 06:02

Express News | Cassava- Topline Data From Phase 3 Refocus-Alz Study of Simufilam in Patients With Mild-to-Moderate Alzheimer's Disease Expected Late Q1/Early Q2 2025

BreakingsJan 8 05:31

Express News | Cassava Sciences Inc: In Final Stages of Discontinuing Refocus-Alz Study

BreakingsJan 8 05:30

Express News | Cassava Sciences Inc: Implementing Cost Curtailment Including a Workforce Reduction of Approximately 33%

BreakingsJan 8 05:30

Express News | Cassava Sciences Provides a Business Update

BreakingsJan 8 05:30

Most Shorted Stocks on Wall Street Heading Into 2025: BYND, KSS, GRPN, and More

Seeking AlphaDec 28, 2024 00:04